Whereas the early studies of cardiomyocyte-specific inactivation of p38 focused on hypertrophy as a cardiomyocyte-specific growth response, more recent work considered also p38α in modulation of intercellular cross-talk during the complex development of cardiac hypertrophy. The gene discussed is MAPK14; the disease is cardiac hypertrophy.